A "biomarker biopsy" for the diagnosis of NASH: Promises from CK-18 fragments

Obesity Surgery

Volumn 18, Issue 11, 2008, Pages 1507-1508

  Yilmaz, Yusuf ^a   Ulukaya, Engin ^a   Dolar, Enver ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; INTERLEUKIN 6; INTERLEUKIN 8; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUIPMENT; HISTOPATHOLOGY; HUMAN; LETTER; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; FATTY LIVER; HUMANS; KERATIN-18; LIVER; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 53849130970     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-008-9639-z     Document Type: Letter

References (5)

1. Younossi ZM, Jarrar M, Nugent C, et al. A novel diagnostic biomarker panel for obesity-related Nonalcoholic Steatohepatitis (NASH). Obes Surg; doi: 10.1007/s11695-008-9506-y
2. Y Yilmaz E Dolar E Ulukaya 2007 Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis World J Gastroenterol 13 837 44
3. A Wieckowska NN Zein LM Yerian 2006 In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease Hepatology 44 27 33
4. DE Kleiner EM Brunt M Van Natta 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313 21
5. T Poynard V Ratziu F Charlotte 2006 Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease BMC Gastroenterol 6 34